Inventor
PARKES DAVID G
US20 patents
⚠️ This page may combine multiple inventors who share the name “PARKES DAVID G”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
LEVY ODILE ESTHER
8 patentsUS8076288B2Dec 13, 2011
Hybrid polypeptides having glucose lowering activity
LEVY ODILE ESTHER49 citations97
US8263545B2Sep 11, 2012
GIP analog and hybrid polypeptides with selectable properties
LEVY ODILE ESTHER62 citations96
US8697647B2Apr 15, 2014
Hybrid polypeptides with selectable properties
LEVY ODILE ESTHER15 citations92
US8603969B2Dec 10, 2013
Pancreatic polypeptide family motifs and polypeptides comprising the same
LEVY ODILE ESTHER19 citations91
US8497240B2Jul 30, 2013
DPP-IV resistant GIP hybrid polypeptides with selectable properties
LEVY ODILE ESTHER25 citations91
US8426361B2Apr 23, 2013
Pancreatic polypeptide family motifs, polypeptides and methods comprising the same
LEVY ODILE ESTHER13 citations91
US8404637B2Mar 26, 2013
GIP analog and hybrid polypeptides with selectable properties
LEVY ODILE ESTHER16 citations91
US8895498B2Nov 25, 2014
GIP and exendin hybrid polypeptides
LEVY ODILE ESTHER0 citations49
AMYLIN PHARMACEUTICALS INC
3 patentsUS7723471B2May 25, 2010
Pancreatic polypeptide family motifs, polypeptides and methods comprising the same
AMYLIN PHARMACEUTICALS INC18 citations91
US7879794B2Feb 1, 2011
Methods for controlling binge eating disorders
AMYLIN PHARMACEUTICALS INC28 citations90
US7671023B2Mar 2, 2010
Amylin agonist for treating depression, anxiety disorder and schizophrenia
AMYLIN PHARMACEUTICALS INC8 citations83
AMYLIN PHARMACEUTICALS LLC
3 patentsUS9453063B2Sep 27, 2016
Hybrid polypeptides with selectable properties
AMYLIN PHARMACEUTICALS LLC0 citations51
US9133260B2Sep 15, 2015
GIP analog and hybrid polypeptides with selectable properties
AMYLIN PHARMACEUTICALS LLC1 citations51
US8906849B2Dec 9, 2014
Pancreatic polypeptide family motifs, polypeptides and methods comprising the same
AMYLIN PHARMACEUTICALS LLC0 citations50